VC
IBB icon

Vicus Capital’s iShares Biotechnology ETF IBB Stock Holding History

Vicus Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,910
Closed -$214K – 234
2019
Q1 		$214K Sell
1,910
-458
-19% -$50.2K 0.03% 219
2018
Q4 		$228K Buy
2,368
+73
+3% +$7.75K 0.04% 200
2018
Q3 		$280K Sell
2,295
-706
-24% -$83.1K 0.05% 192
2018
Q2 		$330K Sell
3,001
-594
-17% -$63.5K 0.05% 183
2018
Q1 		$384K Sell
3,595
-661
-16% -$73.3K 0.07% 169
2017
Q4 		$454K Sell
4,256
-55
-1% -$5.88K 0.08% 156
2017
Q3 		$480K Sell
4,311
-18
-0.4% -$1.92K 0.09% 152
2017
Q2 		$448K Sell
4,329
-465
-10% -$45.8K 0.09% 151
2017
Q1 		$469K Buy
4,794
+72
+2% +$6.89K 0.1% 148
2016
Q4 		$418K Sell
4,722
-1,371
-23% -$125K 0.09% 153
2016
Q3 		$588K Sell
6,093
-354
-5% -$33.7K 0.13% 127
2016
Q2 		$553K Buy
6,447
+636
+11% +$57.1K 0.13% 115
2016
Q1 		$505K Sell
5,811
-10,638
-65% -$951K 0.11% 115
2015
Q4 		$1.85M Sell
16,449
-37,341
-69% -$4.05M 0.47% 59
2015
Q3 		$5.44M Sell
53,790
-5,259
-9% -$631K 1.44% 23
2015
Q2 		$7.26M Buy
59,049
+3,423
+6% +$410K 1.89% 17
2015
Q1 		$6.37M Buy
55,626
+5,304
+11% +$585K 1.23% 18
2014
Q4 		$5.09M Buy
+50,322
New +$4.89M 1.47% 21

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Vicus Capital's IBB Position: Q2 2019 in Review

Vicus Capital sold out of iShares Biotechnology ETF (IBB) in Q2 2019, closing a stake of 1,910 shares — an estimated $214K sold.

Vicus Capital first reported a position in IBB in Q4 2014 and held it in 18 quarters. The position peaked at $7.26M in Q2 2015. 646 funds tracked by Wall St. Rank hold IBB as of Q2 2019.

  • Vicus Capital reported no remaining iShares Biotechnology ETF position as of Q2 2019 after selling out during the quarter.
  • Vicus Capital sold 1,910 iShares Biotechnology ETF shares in Q2 2019, an estimated $214K.
  • Vicus Capital first reported a position in iShares Biotechnology ETF in Q4 2014 and held it in 18 quarters.
  • Vicus Capital's iShares Biotechnology ETF position peaked at $7.26M in Q2 2015.
  • 646 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2019.

Based on Vicus Capital's 13F filing for Q2 2019, filed 8 Aug 2019.